Effectiveness of switching from long-acting injectable fluphenazine or haloperidol decanoate to long-acting injectable risperidone microspheres: an open-label, randomized controlled trial. [electronic resource]
Producer: 20120829Description: 669-75 p. digitalISSN:- 1555-2101
- Antipsychotic Agents -- administration & dosage
- Connecticut
- Delayed-Action Preparations
- Drug Substitution
- Female
- Fluphenazine -- administration & dosage
- Follow-Up Studies
- Haloperidol -- administration & dosage
- Humans
- Hyperprolactinemia -- chemically induced
- Injections
- Intention to Treat Analysis
- Kaplan-Meier Estimate
- Male
- Microspheres
- Middle Aged
- Patient Compliance
- Proportional Hazards Models
- Risperidone -- administration & dosage
- Schizophrenia -- drug therapy
- Weight Gain
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.